34th ICPE: Pharmacoepidemiologic Considerations for Biologics & Biosimilars

Pharmacoepidemiologic Considerations for Biologics & Biosimilars

Key:

Complete
Failed
Available
Locked
Pharmacoepidemiologic Considerations for Biologics & Biosimilars
Recorded 08/23/2018
Recorded 08/23/2018 on-demand educational content